These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7669630)

  • 21. Treatment of toenail onychomycosis. Prescribing terbinafine to every patient with the condition would be expensive.
    Rose P; Wilson T
    BMJ; 1999 Oct; 319(7218):1197. PubMed ID: 10610152
    [No Abstract]   [Full Text] [Related]  

  • 22. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine.
    Elewski BE
    Arch Dermatol; 1997 Oct; 133(10):1317-8. PubMed ID: 9382581
    [No Abstract]   [Full Text] [Related]  

  • 23. Onychomycosis. New therapies for an old disease.
    Gupta AK; Scher RK; De Doncker P; Sauder DN; Shear NH
    West J Med; 1996 Dec; 165(6):349-51. PubMed ID: 9000854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of oral terbinafine for toenail onychomycosis.
    Pollak R; Billstein SA
    J Am Podiatr Med Assoc; 1997 Dec; 87(12):565-70. PubMed ID: 9425805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
    Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungal nail infection: assessing the new treatment options.
    Botek G
    Cleve Clin J Med; 2003 Feb; 70(2):110-4, 117-8. PubMed ID: 12636343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toenail onychomycosis in patients with acquired immune deficiency syndrome: treatment with terbinafine.
    Herranz P; García J; De Lucas R; González J; Peña JM; Díaz R; Casado M
    Br J Dermatol; 1997 Oct; 137(4):577-80. PubMed ID: 9390334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General aspects of drug interactions with systemic antifungals in a retrospective study sample.
    Schmitt JV; Bombonatto G; Trierweiler SM; Fabri AB
    An Bras Dermatol; 2013; 88(3):476-9. PubMed ID: 23793213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
    Ranawaka RR; Nagahawatte A; Gunasekara TA
    Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial.
    Goodfield MJ
    Br J Dermatol; 1992 Feb; 126 Suppl 39():33-5. PubMed ID: 1531926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
    Ornstein DL; Ely P
    J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023
    [No Abstract]   [Full Text] [Related]  

  • 35. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 36. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of superficial white onychomycosis with topical terbinafine cream.
    Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Sep; 141(3):604-5. PubMed ID: 10583101
    [No Abstract]   [Full Text] [Related]  

  • 38. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
    Farkas B; Paul C; Dobozy A; Hunyadi J; Horváth A; Fekete G
    Br J Dermatol; 2002 Feb; 146(2):254-60. PubMed ID: 11903236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-dermatophytic onychomycosis. An understimated entity? A study of 51 cases.
    Gianni C; Cerri A; Crosti C
    Mycoses; 2000; 43(1-2):29-33. PubMed ID: 10838843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onychomycosis--treatment, relapse and re-infection.
    Hull PR
    Dermatology; 1997; 194 Suppl 1():7-9. PubMed ID: 9154393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.